cbdMD (YCBD) Change in Receivables (2017 - 2025)
cbdMD (YCBD) posted Change in Receivables of $76755.0 for Q4 2025, down 83.2% sequentially from $456916.0 in Q3 2025, and down 73.44% YoY from $288936.0 in Q4 2024.
cbdMD (YCBD) Change in Receivables (2017 - 2025) Analysis & Trends
cbdMD has reported Change in Receivables for 9 years, with the latest figure at $76755.0 in Q4 2025.
- Quarterly Change in Receivables fell 73.44% year-over-year to $76755.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $227384.0 (up 27.57% YoY) and the FY2025 annual result came in at $439565.0, up 347.14% from the prior year.
- Change in Receivables eased to $76755.0 in Q4 2025 per YCBD's latest filing, from $456916.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.0 million in Q1 2021 and troughed at -$815369.0 in Q2 2022.
- A 5-year average of $14412.3 and a median of -$27183.5 in 2021 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2021 and 2022: Change in Receivables soared 13544.47% in 2021, then sank 11957.77% in 2022.
- Over 5 years, Change in Receivables stood at -$4554.0 in 2021, then tumbled by 11957.77% to -$549111.0 in 2022, then jumped by 87.77% to -$67169.0 in 2023, then surged by 530.16% to $288936.0 in 2024, then plunged by 73.44% to $76755.0 in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered $76755.0, $456916.0, and -$84759.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76,755.00 |
| Dec 31, 2025 | 76,755.00 |
| Sep 30, 2025 | 456,916.00 |
| Sep 30, 2025 | 456,916.00 |
| Jun 30, 2025 | -84,759.00 |
| Jun 30, 2025 | -84,759.00 |
| Mar 31, 2025 | -221,528.00 |
| Mar 31, 2025 | -221,528.00 |
| Dec 31, 2024 | 288,936.00 |
| Dec 31, 2024 | 288,936.00 |
| Sep 30, 2024 | 75,503.00 |
| Sep 30, 2024 | 75,503.00 |
| Jun 30, 2024 | 47,771.00 |
| Jun 30, 2024 | 47,771.00 |
| Mar 31, 2024 | -233,963.00 |
| Mar 31, 2024 | -233,963.00 |
| Dec 31, 2023 | -67,169.00 |
| Dec 31, 2023 | -67,169.00 |
| Sep 30, 2023 | 57,609.00 |
| Sep 30, 2023 | 57,609.00 |